通过干细胞基因治疗结合非骨髓缩条件的治疗来纠正ADA-SCID
Alessandro Aiuti1, Shimon Slavin, Memet Aker
1San Raffaele Telethon Institute for Gene Therapy (HSR-TIGET), Milan, Italy.
概括
血造干细胞 (HSC) 基因治疗缺少腺氨酸酶 (ADA) 的严重综合免疫缺陷 (SCID) 是有前途的. 一项采用非骨髓衰变条件的新方案导致两名患者的持续移植和改善免疫功能.
科学领域:
- 免疫学 免疫学 免疫学
- 血液学 血液学 血液学
- 基因治疗 基因治疗
背景情况:
- 缺乏腺胺酶 (ADA) 的严重综合免疫缺陷 (SCID) 的治疗具有挑战性.
- 目前用于SCID的造血干细胞 (HSC) 基因疗法由于纠正的HSC的植入率较低,因此有效性有限.
研究的目的:
- 评估一种改进的基因转移到高血压细胞的协议,并与非骨髓衰变条件结合,用于ADA-SCID治疗.
- 评估单独基因治疗在ADA-SCID患者中的安全性和有效性.
主要方法:
- 开发了一个改进的协议,用于将基因转移到HSC中.
- 对患者进行非骨髓衰变调节的治疗.
- 在接受治疗的患者中评估了移植,分化,免疫功能和临床结果.
主要成果:
- 实现了基因工程HSCs的持续植入,具有多个谱系差异化.
- 观察到淋巴细胞数量增加和免疫功能改善,包括抗原特异性反应.
- 证明有毒代谢物减少,导致临床上健康的患者具有正常的生长和发育.
结论:
- 结合非骨髓衰竭条件的HSC基因疗法对于ADA-SCID是安全有效的.
- 这种方法为SCID患者提供了可行的治疗选择,特别是当酶替代疗法无法使用时.
相关概念视频
Gene Therapy
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
iPS Cell Differentiation
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.


